BeiGene

"I've come so far. It was a very difficult process, but I'm here today." Richard, a courageous patient who was living with esophageal cancer, shares his powerful story of diagnosis and treatment. His journey embodies resilience, hope, and strength in the face of cancer.   Watch the video and let Richard's story remind us all of the importance of support, community, and never giving up. #ESCC #EsophagealCancer #PatientsFirst

Members of our Global Medical Affairs, Clinical Development and Clinical Operations teams recently attended the Tigerlily Beacon Symposium and EmPOWER Event, where they engaged in meaningful discussions on important breast cancer topics with the patient community. These conversations focused on access to clinical trials, health equity, as well as the impact of healthcare policies on drug affordability and innovation.  As a Hope Sponsor for both events, we’re honored to support the Tigerlily Foundation in its mission to empower young women throughout their breast cancer journeys. #BreastCancerAwarenessMonth 

This week I had the opportunity to engage with BeiGene employees across various departments this week, discussing the profound impact we’re making in the solid tumor franchise. I take immense pride in our team's relentless dedication to improving the lives of patients around the world. Read my full article below.

We believe in the power of storytelling. By sharing diverse narratives, we build a strong community of voices united against cancer. Elise, a patient with CLL, highlights the important role of clinical trials in her treatment journey and the importance of education for patients to explore every option.  We’re thankful for patients like her, who share their experiences to offer hope and encouragement to others.   Discover how clinical trials and informed decisions have empowered Elise in her CLL journey: https://bit.ly/3BWLF2Z   #Believe #PatientsFirst #CLL #ClinicalTrials 

BeiGene mourns the death of beloved Board member and the chair of the nominating and corporate governance committee, Donald Glazer. Read the full press release here: https://bit.ly/3A63s7v

This week, I received an inspiring message from the The Max Foundation, highlighting a pivotal milestone for BeiGene. Our BTK Inhibitor was successfully launched in Ethiopia for CLL patients at Black Lion Hospital. The message from the doctor on the ground conveyed the profound impact: patients are now filled with excitement and hope, while the hematology team is both motivated and relieved to have access to a first-line therapy that would have been unattainable for decades. At BeiGene, we are committed to putting patients at the heart of everything we do. Their courage and resilience inspire us daily, driving our relentless pursuit to expand access to life-changing therapies worldwide.

We believe we can change the lives of patients and their loved ones. Our state-of-the-art manufacturing and clinical R&D facility in Hopewell, N.J. leverages speed, efficiency and technology to broaden our clinical footprint and accelerate the development of impactful medicines for cancer patients worldwide. Learn more about our efforts to build one of the most prolific oncology pipelines in the industry: https://lnkd.in/eWtqN65H. #Believe #PatientsFirst

October is Health Literacy Month, a time to emphasize the importance of accessible health information and a more navigable healthcare system.    Join us in spreading awareness, improving health education, and supporting patients globally. By collectively working to improve health literacy, we’ll create a more equitable world where everyone can access high-quality care and achieve positive health outcomes.    Explore more about health literacy in our Talk About It blog at https://bit.ly/40AJexB #TalkAboutIt #HealthLiteracyMonth

We’re proud to share the National Association of Specialty Pharmacy (NASP) has named us the Manufacturer of the Year. This peer-nominated and reviewed award recognizes our commitment to working collaboratively with specialty pharmacy stakeholders to advance patient care and drive better clinical outcomes.   Learn more at https://bit.ly/4dWBCZ8. #PatientsFirst

BeiGene was proud to welcome BIO President and CEO John F. Crowley to our flagship U.S. facility at the Princeton West Innovation Campus in Hopewell, N.J. last week. We were excited to showcase our state-of-the-art manufacturing facility and the important work being done by our colleagues to expand patient access to life-changing #cancer medicines. Strategic Advisor and Special Assistant to the CEO, Michael Schoen, who serves on the Biotechnology Innovation Organization Board and hosted the visit, shared BeiGene’s patients-first mission and commitment to affordability and innovation.